跳至主要内容
临床试验/NCT07675096
NCT07675096尚未招募不适用

Super-voltage Pulsed Radiofrequency of Stellate Ganglion Versus Super-voltage Pulsed Radiofrequency of T2 T3 Sympathetic Ganglia in Managing Postmastectomy Pain Syndrome.

National Cancer Institute, Egypt1 个研究点 分布在 1 个国家目标入组 75 人开始时间: 2026年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
75
试验地点
1
主要终点
Change in VAS score in groups

研究概览

简要总结

The aim of this study is to compare the effectiveness of super-voltage pulsed radiofrequency of stellate ganglion and super-voltage pulsed radiofrequency of T2-T3 sympathetic ganglia in the treatment of postmastectomy pain syndrome.

详细描述

Rationale for our study:

Supervoltage Pulsed Radiofrequency (SV-PRF) is an advanced neuromodulation technique that delivers higher-voltage short pulses (typically 60-90 V) while keeping tissue temperature below neurodestructive levels (<42°C), allowing deeper electric-field penetration, enhanced C-fiber modulation, and sustained changes in sympathetic outflow without causing structural nerve injury, theoretically providing longer-lasting analgesia and improved safety compared to standard PRF. Among interventional options for sympathetically mediated PMPS, stellate ganglion (SGB) and T2-T3 sympathetic interventions have emerged as promising therapies, yet they differ in mechanism, outcomes, and clinical implications. The current literature lacks direct head-to-head comparisons of these two techniques regarding efficacy, long-term relief, and safety, as most studies evaluate each intervention individually. This knowledge gap, combined with the limited efficacy of conventional pharmacologic treatments, highlights the need for a comparative study to determine which approach offers superior pain relief, durability, safety, and cost-effectiveness. By examining short- and long-term outcomes, as well as resource utilization, this study aims to provide evidence-based guidance to optimize clinical decision-making, help clinicians select the most appropriate intervention for PMPS patients, and establish practical, sustainable treatment strategies. .(33, 34)

Aim of the study:

The aim of this study is to compare the effectiveness of supervoltage pulsed radifrequency of stellate ganglion and supervoltage pulsed radifrequency of T2-T3 sympathetic ganglia in the treatment of postmastectomy pain syndrome.

Primary Objectives:

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Female patients aged 18-60 years.
  • Patient of class II according to the American society of Anesthesiologists (ASA) physical status classification system.
  • History of unilateral mastectomy for breast cancer.
  • Persistent pain >3 months postoperatively.
  • VAS score ≥4 despite pharmacological management.
  • Patients with neuropathic pain who has a score ≥4 by (DN4) questionnaire.
  • Patients on more than 1 antineuropathic drug.

排除标准

  • Coagulopathy or anticoagulant therapy.
  • Local infection at injection site.
  • History of psychiatric illness or cognitive dysfunction.
  • Previous intervention in the same region (e.g., prior stellate ganglion block or thoracic radiofrequency ablation).
  • Allergy to local anesthetics or contrast agents.

结局指标

主要结局

Change in VAS score in groups

时间窗: 6 months

Change in visual analogue scale score in groups at different time intervals (baseline, 1 week, 1 month, 3 months, 6 months)

次要结局

  • Change in Brief Pain Inventory in groups.(6 months)
  • Patient satisfaction(6 months)
  • dose reduction in antineuropathic drugs(6 months)
  • procedural complications.(6 months)

研究者

发起方
National Cancer Institute, Egypt
申办方类型
Other
责任方
Principal Investigator
主要研究者

Ahmed Mohamed Soliman

Assistant professor of anesthesia and pain management

National Cancer Institute, Egypt

研究点 (1)

Loading locations...

相似试验

Super-voltage PRF of Stellate Ganglion Versus... | 临床试验